Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Warning! One buflomedil may hide another one!

A Chiffoleau1, D Yatim, F Garrec

  • 1Centre Régional de Pharmacovigilance, Institut de Biologie, Nantes, France.

Therapie
|June 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Severe systemic vasculitis induced by ibrutinib].

La Revue de medecine interne·2023
Same author

Delayed eczematous skin reaction as an adverse drug reaction to immunoglobulin infusions: A case series.

Annales de dermatologie et de venereologie·2022
Same author

Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France.

Medicina oral, patologia oral y cirugia bucal·2019
Same author

Pristinamycin-induced arthralgia and myalgia: Analysis of the French Pharmacovigilance Database.

Medecine et maladies infectieuses·2017
Same author

Combined effect of divergent selection for breast muscle ultimate pH and dietary amino acids on chicken performance, physical activity and meat quality.

Animal : an international journal of animal bioscience·2016
Same author

5-HT2C receptors in psychiatric disorders: A review.

Progress in neuro-psychopharmacology & biological psychiatry·2016
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

A patient taking Buflomedil experienced adverse effects due to accidentally taking both the original and generic versions. This highlights the critical need for clear patient communication regarding medication changes and generic substitutions.

Area of Science:

  • Pharmacology
  • Clinical Toxicology

Background:

  • Buflomedil is a vasoactive drug used to treat peripheral arterial disease.
  • Medication adherence and accurate dosing are crucial for patient safety.

Observation:

  • A 75-year-old woman presented with fever and convulsions.
  • She was treated with Buflomedil Merck for arteritis, with elevated blood levels detected.
  • Symptoms resolved after discontinuing the medication.

Findings:

  • The patient had inadvertently taken both Fonzylane (original) and Buflomedil Merck (generic) concurrently.
  • This dual usage, not a product failure, led to supratherapeutic Buflomedil levels and adverse events.

Implications:

  • Emphasizes the risk of medication misuse when generic substitutions are not clearly communicated to patients.

Related Experiment Videos

  • Highlights the importance of comprehensive patient education regarding drug changes and potential for accidental duplication.
  • Underscores the role of pharmacists in identifying and resolving complex medication-related issues.